These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1663730)

  • 1. Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonylmethoxyethyl)adenine (PMEA).
    Hoover EA; Ebner JP; Zeidner NS; Mullins JI
    Antiviral Res; 1991 Jul; 16(1):77-92. PubMed ID: 1663730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms.
    Hartmann K; Donath A; Beer B; Egberink HF; Horzinek MC; Lutz H; Hoffmann-Fezer G; Thum I; Thefeld S
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):167-75. PubMed ID: 1363008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS).
    Zeidner NS; Rose LM; Mathiason-DuBard CK; Myles MH; Hill DL; Mullins JI; Hoover EA
    J Acquir Immune Defic Syndr (1988); 1990; 3(8):787-96. PubMed ID: 2164083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 9-(2-phosphonylmethoxyethyl) adenine therapy for feline immunodeficiency virus using a quantitative polymerase chain reaction.
    Philpott MS; Ebner JP; Hoover EA
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):155-66. PubMed ID: 1337395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective impairment of humoral immunity in feline leukemia virus-induced immunodeficiency.
    Pardi D; Hoover EA; Quackenbush SL; Mullins JI; Callahan GN
    Vet Immunol Immunopathol; 1991 Jul; 28(3-4):183-200. PubMed ID: 1659028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
    Hoover EA; Zeidner NS; Perigo NA; Quackenbush SL; Strobel JD; Hill DL; Mullins JI
    Intervirology; 1989; 30 Suppl 1():12-25. PubMed ID: 2540109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.
    Quackenbush SL; Donahue PR; Dean GA; Myles MH; Ackley CD; Cooper MD; Mullins JI; Hoover EA
    J Virol; 1990 Nov; 64(11):5465-74. PubMed ID: 1976822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.
    Egberink H; Borst M; Niphuis H; Balzarini J; Neu H; Schellekens H; De Clercq E; Horzinek M; Koolen M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3087-91. PubMed ID: 2158102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
    Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication kinetics and cell tropism of an immunosuppressive feline leukaemia virus.
    Quackenbush SL; Mullins JI; Hoover EA
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1411-20. PubMed ID: 8757981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virus.
    Hartmann K; Kuffer M; Balzarini J; Naesens L; Goldberg M; Erfle V; Goebel FD; De Clercq E; Jindrich J; Holy A; Bischofberger N; Kraft W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):120-8. PubMed ID: 9473012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and adverse effects of the antiviral compound plerixafor in feline immunodeficiency virus-infected cats.
    Hartmann K; Stengel C; Klein D; Egberink H; Balzarini J
    J Vet Intern Med; 2012; 26(3):483-90. PubMed ID: 22551322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo.
    Quackenbush SL; Dean GA; Mullins JI; Hoover EA
    Virology; 1996 Sep; 223(1):1-9. PubMed ID: 8806534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon.
    Hoover EA; Zeidner NS; Mullins JI
    Ann N Y Acad Sci; 1990; 616():258-69. PubMed ID: 1964030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys.
    Balzarini J; Naesens L; Slachmuylders J; Niphuis H; Rosenberg I; Holý A; Schellekens H; De Clercq E
    AIDS; 1991 Jan; 5(1):21-8. PubMed ID: 2059358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.
    Vahlenkamp TW; De Ronde A; Balzarini J; Naesens L; De Clercq E; van Eijk MJ; Horzinek MC; Egberink HF
    Antimicrob Agents Chemother; 1995 Mar; 39(3):746-9. PubMed ID: 7793884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.
    Donahue PR; Quackenbush SL; Gallo MV; deNoronha CM; Overbaugh J; Hoover EA; Mullins JI
    J Virol; 1991 Aug; 65(8):4461-9. PubMed ID: 1649341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
    Zeidner NS; Myles MH; Mathiason-DuBard CK; Dreitz MJ; Mullins JI; Hoover EA
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1749-56. PubMed ID: 2178336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response.
    Mathes LE; Polas PJ; Hayes KA; Swenson CL; Johnson S; Kociba GJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2715-21. PubMed ID: 1336345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.